Related Experiment Video

Updated: Jun 20, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc

Mario Huesca1, Lisa S Lock, Aye Aye Khine

  • 1Lorus Therapeutics Inc., Toronto, Ontario M9W 4Z7 Canada. mhuesca@lorusthera.com

Molecular Cancer Therapeutics
|September 17, 2009
PubMed

Insights

ML-133, a novel small molecule, exhibits potent antiproliferative and antitumor activity by modulating intracellular zinc levels. This leads to cell cycle arrest, suggesting a new strategy for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer cell proliferation is a hallmark of the disease.
  • Targeting cell cycle regulation is a key strategy in cancer therapy.
  • Intracellular zinc homeostasis plays a role in cellular processes.

Purpose of the Study:

  • To investigate the antiproliferative and antitumor effects of ML-133.
  • To elucidate the molecular mechanism of ML-133 action.
  • To evaluate ML-133 as a potential cancer therapeutic agent.

Main Methods:

  • In vitro antiproliferative assays using cancer cell lines.
  • In vivo studies using a human colon tumor xenograft model.
  • Analysis of intracellular labile zinc concentrations and transcription factor induction.

Main Results:

  • ML-133 demonstrated potent antiproliferative activity in cancer cell lines and xenografts.
  • ML-133 reduced intracellular labile zinc in HT-29 colon cancer cells.
  • ML-133 induced Krüppel-like factor 4, leading to G(1)-S phase arrest via cyclin D1 regulation.

Conclusions:

  • Modulation of intracellular zinc homeostasis is a viable strategy for cancer treatment.
  • ML-133 exhibits significant antitumor potential and warrants further development.
  • ML-133 represents a promising new class of anticancer agents.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...